Dr. Reiner is Professor in the National Core for Neuroethics and a member of the Kinsmen Laboratory of Neurological Research, Department of Psychiatry and the Brain Research Centre at the University of British Columbia. Dr. Reiner has a distinguished track record as a research scientist studying the neurobiology of behavioral states and the molecular underpinnings of neurodegenerative disease. Dr. Reiner also has experience in the private sector, having been President and CEO of Active Pass Pharmaceuticals, a drug discovery company that he founded to tackle the scourge of Alzheimer’s disease. Upon returning to academic life, Dr. Reiner refocused his scholarly work in the area of neuroethics, with interests in neuroessentialism, the neuroethics of cognitive enhancement, and the commercialization of neuroscience.
Co-Principal Investigator Awards
Lecture: Neuromodulation today and tomorrow: can doctors change my brain functions?
The talk will provide an overview of the current and future possibilities to modulate the activities of the human brain. She will particularly focus on ethical, neurological and psychiatric aspects of deep brain stimulation.